Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection.
Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection.
复制标题
DOI:
10.4049/jimmunol.1001751
复制
发表时间:
2011-01-15
期刊:
影响因子:
--
通讯作者:
Rosenberg HF
中科院分区:
文献类型:
--
作者:
Gabryszewski SJ;Bachar O;Dyer KD;Percopo CM;Killoran KE;Domachowske JB;Rosenberg HF
The inflammatory response to respiratory virus infection can be complex and refractory to standard therapy. Lactobacilli, when targeted to the respiratory epithelium, are highly effective at suppressing virus-induced inflammation and protecting against lethal disease. Specifically, wild-type mice primed via intranasal inoculation with live or heat-inactivated Lactobacillus plantarum or Lactobacillus reuteri were completely protected against lethal infection with the virulent rodent pathogen, pneumonia virus of mice (PVM); significant protection (60% survival) persisted for at least thirteen weeks. Protection was not unique to Lactobacillus species, and was also observed in response to priming with non-pathogenic gram-positive Listeria innocua. Priming with live lactobacilli resulted in diminished granulocyte recruitment, diminished expression of multiple proinflammatory cytokines (CXCL10, CXCL1, CCL2, and TNF) and reduced virus recovery, although we have demonstrated clearly that absolute virus titer does not predict clinical outcome. Lactobacillus priming also resulted in prolonged survival and protection against the lethal sequelae of PVM infection in MyD88 gene-deleted (MyD88−/−) mice, suggesting that the protective mechanisms may be Toll-like receptor-independent. Most intriguing, virus recovery and cytokine expression patterns in Lactobacillus-primed MyD88−/− mice were indistinguishable from those observed in control-primed MyD88−/− counterparts, In summary, we have identified and characterized an effective Lactobacillus-mediated innate immune shield, which may ultimately serve as critical and long-term protection against infection in the absence of specific antiviral vaccines.
登录
查看更多内容
影响因子:
5.4
作者:
Bonville, CA;Easton, AJ;Domachowske, JB
通讯作者:
Domachowske, JB
DOI:
10.1056/nejmoa0804877
发表时间:
2009-02-05
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hall CB;Weinberg GA;Iwane MK;Blumkin AK;Edwards KM;Staat MA;Auinger P;Griffin MR;Poehling KA;Erdman D;Grijalva CG;Zhu Y;Szilagyi P
通讯作者:
Szilagyi P
DOI:
10.1099/00221287-143-8-2733
发表时间:
1997-08-01
期刊:
MICROBIOLOGY-UK
影响因子:
--
作者:
Hols, P;Slos, P;Mercenier, A
通讯作者:
Mercenier, A
影响因子:
15.3
作者:
Didierlaurent, Arnaud;Goulding, John;Patel, Seema;Snelgrove, Robert;Low, Lionel;Bebien, Magali;Lawrence, Toby;van Rijt, Leonie S.;Lambrecht, Bart N.;Sirard, Jean-Claude;Hussell, Tracy
通讯作者:
Hussell, Tracy
影响因子:
2.4
作者:
Harata, G.;He, F.;Yausi, H.
通讯作者:
Yausi, H.